trending

Elon Musk’s stocks lose $1.5 trillion this month Elon Musk's companies lose $1.5 trillion as SpaceX faces earnings and insider lockup challenges Big Tech bets $700 billion on AI as earnings season begins Big Tech shifts focus to $700 billion AI investment, sparking debate on potential over-investment. Can U.S. AI keep its edge against Chinese rivals? Ahron Young explores U.S. Can diplomacy prevent a wider Middle East conflict? Ahron Young examines U.S. military actions and Middle East diplomacy amid rising conflict threats Apple surpasses Nvidia as most valuable company Apple reclaims title of world's most valuable company, surpassing Nvidia amid dips in AI chip stocks France and Spain battle wildfires before heatwave France and Spain race to combat wildfires before another heatwave hits, evacuating thousands. Trump claims US-Iran talks are positive amid drone attacks Trump claims U.S. and Iran having 'good talks' amid drone strikes on Iran's neighbours. Vehicle attack during Berlin Pride injures many Berlin Pride attacked as vehicle crashes into crowd, killing one and injuring many, prompting community grief. AusAlert emergency warning test across millions of Australian devices AusAlert emergency warning system test set for today across millions of Australian devices at 2pm AEST Alan Joyce admits errors during Qantas leadership Alan Joyce reflects on errors as former Qantas CEO, takes accountability for pandemic mistakes. How the federal budget was built on a major lie For months the Federal Government has been telling Australians that property investors are the villains of the… Qantas A350 1000ULR Project Sunrise arrives at Melbourne Airport Qantas welcomes first Airbus A350-1000ULR, paving way for ultra-long-haul flights. Why billions in US tariff refunds won’t repair global trade Tariffs not designed to last Trump’s UAE tech deal sparks security concerns Trump administration faces backlash over UAE technology access. Impact of Trump’s drug tariff on global healthcare Ahron Young examines Trump's proposed drug tariff and its impact on U.S. manufacturing and global healthcare costs